Skip to main content
News

Cancer Vaccine No Longer a Fantasy

Photo 1 of 1

Moderna's personalized melanoma vaccine has reached the primary endpoint of its Phase 3 trial.

It is created based on a 'portrait' of the tumor. The result is a personalized antiviral that teaches the immune system to destroy cancer cells remaining after surgery.

Full data hasn't been published yet, and this is not yet a cure for all types of cancer, but the technology has already worked in human trials. If the approach is confirmed for other tumors, cancer will increasingly be stopped before recurrence.

Read also